Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 6.545% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
(a) CCCc1cc(C(=O)NCC(C)C)no1
(b) CN(C(=O)CCc1nnc(-c2ccc(-c3ccccc3)cc2)o1)C1CCOCC1
(c) COC(=O)C(COC(=O)c1c(F)cccc1F)NC(=O)c1c(F)cccc1F
(d) Cc1nn(C)cc1/C=N/NC(=O)CSc1ccccn1
Answer: d. Cc1nn(C)cc1/C=N/NC(=O)CSc1ccccn1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nn(C)cc1/C=N/NC(=O)CSc1ccccn1
Cc1nn(C)cc1/C=N/NC(=O)CSc1ccccn1
N-[(E)-(1,3-dimethylpyrazol-4-yl)methylideneamino]-2-pyridin-2-ylsulfanylacetamide